Frincke; James M
Patent Applications and Registrations
Patent applications and USPTO patent grants for Frincke; James M.The latest application filed is for "17-substituted steroid compounds".
Company Profile
0.31.53
- Frincke; James M - Del Mar CA
- Frincke; James M. - San Diego CA
- Frincke; James M. - Del Mar CA
- Frincke; James M. - Carlsbad CA US
- Frincke; James M. - Solana Beach CA
- Frincke; James M. - Olivenhain CA
Patent Activity
| Patent | Date |
|---|---|
| 17-Substituted Steroid Compounds App 20150353596 - Frincke; James M | 2015-12-10 |
| Steroids having 7-oxygen and 17-heteroaryl substitution-3 Grant 9,115,168 - Frincke August 25, 2 | 2015-08-25 |
| Steroids having 7-oxygen and 17-heteroaryl substitution-2 Grant 9,102,702 - Frincke August 11, 2 | 2015-08-11 |
| Steroids Having 7-Oxygen and 17-Heteroaryl Substitution-2 App 20140018336 - Frincke; James M. | 2014-01-16 |
| Steroids Having 7-Oxygen and 17-Heteroaryl Substitution-3 App 20140018337 - Frincke; James M. | 2014-01-16 |
| Treatment of Ocular Diseases App 20140010806 - Frincke; James M. ; et al. | 2014-01-09 |
| Unsaturated steroid compounds Grant 8,586,770 - Frincke November 19, 2 | 2013-11-19 |
| Steroids having 7-oxgen and 17-heteroaryl substitution Grant 8,569,275 - Frincke October 29, 2 | 2013-10-29 |
| 11-aza, 11-thia and 11-oxa sterol compounds and compositions Grant 8,541,600 - Frincke September 24, 2 | 2013-09-24 |
| Steroid compounds and treatment methods Grant 8,367,646 - Frincke February 5, 2 | 2013-02-05 |
| Drug identification and treatment method Grant 8,354,396 - Frincke , et al. January 15, 2 | 2013-01-15 |
| Drug screening and treatment methods Grant 8,217,025 - Flores-Riveros , et al. July 10, 2 | 2012-07-10 |
| 15-thia Steroid Compounds And Compositions App 20120101052 - Frincke; James M. | 2012-04-26 |
| Steroid Compounds and Treatment Methods App 20120071454 - Frincke; James M. | 2012-03-22 |
| 11-Aza, 11-Thia and 11-Oxa Sterol Compounds and Compositions App 20120041016 - Frincke; James M. | 2012-02-16 |
| Screening and Treatment Method App 20120029260 - Garsd; Armando ; et al. | 2012-02-02 |
| Pharmaceutical compositions-4 Grant 8,106,036 - Frincke January 31, 2 | 2012-01-31 |
| Steroid compounds and formulations Grant 8,076,316 - Frincke December 13, 2 | 2011-12-13 |
| Compounds and compositions Grant 8,022,234 - Frincke September 20, 2 | 2011-09-20 |
| 15-thia Steroid Compounds And Compositions App 20110218162 - Frincke; James M. | 2011-09-08 |
| Compositions And Treatment Methods-4 App 20110212935 - Frincke; James M. | 2011-09-01 |
| Unsaturated Steroid Compounds App 20110137057 - Frincke; James M. | 2011-06-09 |
| Anticancer Compounds And Screening Method App 20110129423 - Frincke; James M. | 2011-06-02 |
| 15-OXA-steroid compounds Grant 7,947,846 - Frincke May 24, 2 | 2011-05-24 |
| Sepsis treatment methods Grant 7,935,839 - Frincke May 3, 2 | 2011-05-03 |
| Steroid Compounds and Formulations App 20110098260 - Frincke; James M. | 2011-04-28 |
| Drug Product and Process for Making App 20110085984 - Frincke; James M. ; et al. | 2011-04-14 |
| Cystic fibrosis treatment methods Grant 7,910,571 - Frincke March 22, 2 | 2011-03-22 |
| Stem cell expansion and uses Grant 7,910,755 - Frincke March 22, 2 | 2011-03-22 |
| Cancer treatment methods Grant 7,906,497 - Frincke March 15, 2 | 2011-03-15 |
| Compounds and compositions App 20110009372 - Frincke; James M. | 2011-01-13 |
| Breast and prostate cancer treatment method Grant 7,863,261 - Frincke January 4, 2 | 2011-01-04 |
| Cancer treatment methods App 20100240633 - Lardy; Henry A. ; et al. | 2010-09-23 |
| Patient populations and treatment methods App 20100227841 - Stickney; Dwight ; et al. | 2010-09-09 |
| Pharmaceutical Compositions-4 App 20100222313 - Frincke; James M. | 2010-09-02 |
| Patient populations and treatment methods App 20100222315 - Reading; Christopher L. ; et al. | 2010-09-02 |
| Compositions And Treatment Methods-2 App 20100222425 - Frincke; James M. | 2010-09-02 |
| Pharmaceutical compositions Grant 7,776,845 - Frincke August 17, 2 | 2010-08-17 |
| Pharmaceutical compositions 3 Grant 7,723,532 - Frincke , et al. May 25, 2 | 2010-05-25 |
| Prostate and breast cancer treatment Grant 7,696,189 - Frincke April 13, 2 | 2010-04-13 |
| Formulations Grant 7,691,835 - Frincke April 6, 2 | 2010-04-06 |
| Patient populations and treatment methods App 20100075937 - Flores-Riveros; Jaime ; et al. | 2010-03-25 |
| Stabilized Therapeutic Compositions And Formulations App 20090258850 - Frincke; James M. ; et al. | 2009-10-15 |
| Therapeutic treatment methods Grant 7,547,687 - Reading , et al. June 16, 2 | 2009-06-16 |
| Steroid Tetrol Solid State Forms App 20090143349 - Lewbart; Marvin L. ; et al. | 2009-06-04 |
| Tetrol steroids and esters Grant 7,524,835 - Frincke April 28, 2 | 2009-04-28 |
| Therapeutic treatment methods Grant 7,482,334 - Frincke , et al. January 27, 2 | 2009-01-27 |
| Drug Screen and Treatment Method App 20080221074 - Flores-Riveros; Jaime ; et al. | 2008-09-11 |
| Pharmaceutical Compositions 3 App 20080176824 - Frincke; James M. ; et al. | 2008-07-24 |
| Breast and Prostate Cancer Treatment Method App 20080176823 - Lardy; Henry A. ; et al. | 2008-07-24 |
| Drug Identification and Treatment Method App 20080153797 - Frincke; James M. ; et al. | 2008-06-26 |
| Drug Identification and Treatment Method App 20080153792 - Frincke; James M. ; et al. | 2008-06-26 |
| Drug Screening and Treatment Methods App 20080146532 - Flores-Riveros; Jaime ; et al. | 2008-06-19 |
| Cystic fibrosis treatment methods App 20080090791 - Reading; Christopher L. ; et al. | 2008-04-17 |
| Disease treatment methods App 20080085873 - Reading; Christopher L. ; et al. | 2008-04-10 |
| Formulations App 20080058301 - Lardy; Henry A. ; et al. | 2008-03-06 |
| Pharmaceutical Compositions App 20080045490 - Frincke; James M. ; et al. | 2008-02-21 |
| Pharmaceutical Compositions App 20080021006 - Lardy; Henry A. ; et al. | 2008-01-24 |
| Metabolic Disease Treatments App 20080015174 - Reading; Christopher L. ; et al. | 2008-01-17 |
| Formulations and Treatment Methods App 20070275936 - Ahlem; Clarence N. ; et al. | 2007-11-29 |
| Therapeutic Treatment Methods App 20070275938 - Reading; Christopher L. ; et al. | 2007-11-29 |
| Therapeutic Treatment Methods App 20070275937 - Reading; Christopher L. ; et al. | 2007-11-29 |
| Asthma Treatment Methods App 20070265236 - Reading; Christopher L. ; et al. | 2007-11-15 |
| Sepsis Treatment Methods App 20070213309 - Reading; Christopher L. ; et al. | 2007-09-13 |
| Pharmaceutical compositions App 20070203107 - Frincke; James M. ; et al. | 2007-08-30 |
| Pharmaceutical treatments and compositions App 20070129282 - Ahlem; Clarence N. ; et al. | 2007-06-07 |
| Surrogate markers App 20070077203 - Garsd; Armando ; et al. | 2007-04-05 |
| Stem cell expansion and uses App 20070077201 - Reading; Christopher L. ; et al. | 2007-04-05 |
| Drug product and process for making App 20070053832 - Frincke; James M. ; et al. | 2007-03-08 |
| Steroid analogs and characterization and treatment methods App 20070014719 - Reading; Christopher L. ; et al. | 2007-01-18 |
| Treatment screening methods App 20060088473 - Dowding; Charles ; et al. | 2006-04-27 |
| Compositions and treatment methods App 20060079492 - Ahlem; Clarence N. ; et al. | 2006-04-13 |
| Treatment screening methods App 20060073099 - Frincke; James M. ; et al. | 2006-04-06 |
| Therapeutic treatment methods 2 App 20050101581 - Reading, Christopher L. ; et al. | 2005-05-12 |
| Therapeutic treatment methods App 20040138187 - Reading, Christopher L. ; et al. | 2004-07-15 |
| Immune modulation method using steroid compounds App 20030060425 - Ahlem, Clarence N. ; et al. | 2003-03-27 |
| Interferon antibody therapeutic compositions having an extended serum half-life Grant 5,055,289 - Frincke , et al. October 8, 1 | 1991-10-08 |
| Non-covalent antibody-anthracycline immunocomplexes Grant 5,004,606 - Frincke , et al. April 2, 1 | 1991-04-02 |
Company Registrations
| SEC | 0001239656 | FRINCKE JAMES M |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 